Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together cancer researchers, oncologists, and advocates to discuss the latest advances in cancer care. While many of the biggest chronic lymphocytic leukemia (CLL) updates are often presented at hematology-focused meetings like American Society of Hematology (ASH), ASCO 2026 still includes important discussions around […]

If you or a loved one has chronic lymphocytic leukemia (CLL), you may have heard about a newer treatment called pirtobrutinib. Recent research is showing promising results, both for people who are newly diagnosed and those whose cancer has come back after treatment. Here’s what you need to know. What is pirtobrutinib? Pirtobrutinib is a […]

Whether you’re in active surveillance or receiving treatment for chronic lymphocytic leukemia (CLL), taking care of your whole body can make a meaningful difference in how you feel each day. Complementary therapies used alongside standard medical treatment can help relieve common side effects such as fatigue, nausea, stress, and changes in appetite. The following supportive […]

For people living with chronic lymphocytic leukemia (CLL), treatment decisions often come with an important question: Is this something I’ll need to take indefinitely, or is there an option that allows for a break? CLL treatment can follow either approach. New data from a large international study is helping clarify how these strategies compare and […]

Each year, the American Society of Hematology (ASH) holds its annual conference to share the latest research and breakthroughs in blood cancers. At this year’s meeting, several studies revealed important new findings for patients with chronic lymphocytic leukemia (CLL). These results highlight advances in treatment options, including new drugs and strategies that may help patients […]